Mark D. Minden
Impact in
-
- Acute Myeloid Leukemia Research
Papers in
-
- Acute Myeloid Leukemia Research 3
- Chronic Myeloid Leukemia Treatments 1
- Oncology 3
- CAR-T cell therapy research 2
- Cancer-related Molecular Pathways 1
- Co-authors
- H. A. Messner (1 shared paper)Samuel Benchimol (1 shared paper)Hong Chang (1 shared paper)John A. Blondal (1 shared paper)Ismat A. Khatri (2 shared papers)Jongbok Lee (2 shared papers)Xiaoyu Zhu (1 shared paper)Martin Jädersten (1 shared paper)
- Journals
- Cancer Cell (1 paper)Journal for ImmunoTherapy of Cancer (1 paper)Journal of Experimental & Clinical Cancer Research (1 paper)Cancer (1 paper)Leukemia Research (1 paper)
- Partner nations
- CanadaUnited StatesUnited Kingdom
In The Last Decade
Mark D. Minden
6 papers receiving 339 citations
Peers
Comparison fields: 5 of 54
- Hematology 68
- Aging 8
- Cancer Research 61
- Cell Biology 61
- Molecular Biology 251
Countries citing papers authored by Mark D. Minden
This map shows the geographic impact of Mark D. Minden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark D. Minden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark D. Minden more than expected).
Fields of papers citing papers by Mark D. Minden
This network shows the impact of papers produced by Mark D. Minden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark D. Minden. The network helps show where Mark D. Minden may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark D. Minden, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 295 | |
| 2 | 1995 | 37 | |
| 3 | 2025 | 3 | |
| 4 | 2025 | 3 | |
| 5 | 2025 | 3 | |
| 6 | 2025 | 2 |
About Mark D. Minden
Mark D. Minden is a scholar working on Hematology, Oncology, Pathology and Forensic Medicine, Immunology and Pulmonary and Respiratory Medicine, having authored 6 papers that have together received 343 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (3 papers), CAR-T cell therapy research (2 papers), Chronic Myeloid Leukemia Treatments (1 paper), Protein Degradation and Inhibitors (1 paper), Cancer-related Molecular Pathways (1 paper), Lymphoma Diagnosis and Treatment (1 paper), Immunotherapy and Immune Responses (1 paper) and Ubiquitin and proteasome pathways (1 paper). The work is most often cited by research in Hematology (68 citations), Aging (8 citations), Cancer Research (61 citations), Cell Biology (61 citations) and Molecular Biology (251 citations). Mark D. Minden has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include H. A. Messner, Samuel Benchimol, Hong Chang, John A. Blondal, Ismat A. Khatri, Jongbok Lee, Xiaoyu Zhu, Martin Jädersten, Monzr M. Al Malki and Amir Tahmasb Fathi. Their work appears in journals such as Cancer Cell, Journal for ImmunoTherapy of Cancer, Journal of Experimental & Clinical Cancer Research, Cancer and Leukemia Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.